Navigation Links
Detailed Cholesterol Test Provides Vital Clues for Women in Search of PCOS Answers
Date:9/9/2010

BIRMINGHAM, Ala., Sept. 9 /PRNewswire/ -- Polycystic Ovarian Syndrome, known as PCOS, is a silent and often mysterious disease that plays havoc with a woman's body and increases the risk of serious illness.

PCOS is the number one cause of female infertility and increases the risk of heart disease, insulin resistance, diabetes and certain cancers. It is also the most common metabolic abnormality in women of child bearing age, affecting 5 to 10 million women nationwide, according to the American Association of  Clinical Endocrinologists. Yet, it is plagued by a lack of awareness and is one of the most difficult diseases to diagnose.

There is no single test for diagnosing the illness, but a detailed cholesterol profile called the VAP Cholesterol Test, along with diet, exercise and the right medication, is changing how doctors approach PCOS and is dramatically altering patients' lives for the better.

"The average patient sees five medical practitioners before getting diagnosed," said Steven Foley, M.D., a Colorado Springs, Colo., gynecologist who specializes in the identification and treatment of patients suffering from PCOS. "That's because the symptoms can vary from woman to woman. Early diagnosis is critical not only in reducing the risk of more serious complications, but because PCOS can be devastating for women physically and emotionally."

Women often spend a tremendous about of time and money searching for answers to these unexplained symptoms and for a doctor who understands the complexities of PCOS. Foley recently used the VAP Test to help diagnose PCOS in a 24-year-old patient who was struggling with weight gain, insulin resistance and high cholesterol levels. The Colorado Springs woman faced the prospect of early heart disease, diabetes and infertility unless her health improved. Foley prescribed a healthy diet, regular exercise and a diabetes medicine that helps to control her insulin and blood sugar levels. He continues to use the VAP Test to manage the woman's PCOS and heart disease risk.

"It is the most accurate and easiest method to evaluate my female patients for elevated cholesterol as well as polycystic ovarian syndrome," Foley said. "It is particularly valuable when developing a treatment plan for women and also helps to monitor response to treatment."

September is PCOS Awareness Month and serves as a reminder for women to have a conversation with their health care provider about PCOS. The four major symptoms of PCOS are irregular periods, weight gain, high testosterone levels and metabolic disorders, including cholesterol problems.

Developed by Atherotech Diagnostics Lab (www.atherotech.com), the VAP Test plays a central role in the diagnosis of PCOS because, unlike the standard cholesterol test, it measures a range of cholesterol subclasses and can be administered without fasting. The VAP Test is widely covered by insurance, and results have shown a correlation between patients who have PCOS and low levels of HDL2, a highly protective subclass of high density lipoprotein (HDL).

Atherotech Diagnostics Lab has seen steadily increasing demand from gynecologists and endocrinologists for the VAP Cholesterol Test. The VAP Test is available nationwide and reports 22 separate components of blood compared to just four in the standard cholesterol test (LDL, HDL, total cholesterol and triglycerides) at no additional cost. For more information call 877.901.8510 or visit www.atherotech.com.

About Atherotech Diagnostics Lab

Atherotech is a CLIA-certified clinical reference laboratory and cardiodiagnostic company focusing on cardiometabolic tests, including the company's patented VAP Cholesterol Test, which reports the cholesterol content of all lipids, components and subclasses. The VAP Test is the first cholesterol profile to comply with updated National Cholesterol Education Program ATP III recommendations for direct LDL measurement, which is accurate with non-fasting samples. The VAP Test is available through national and regional diagnostic laboratories and is reimbursed by many of the largest private insurers as well as Medicare. For more information, visit www.atherotech.com.


'/>"/>
SOURCE Atherotech Diagnostics Lab
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MedQuist Performance Monitor Offers Transparency, Detailed Reporting and Measurement of Clinical Documentation Metrics
2. People at Intermediate Risk of Heart Disease With Elevated hsCRP Benefit From Statin Therapy Even if Cholesterol Levels are Normal
3. Amsterdam Molecular Therapeutics Reports Promising Data From Cholesterol Lowering Gene Therapy Study
4. New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes
5. Mylan Confirms First-to-File Patent Challenge Relating to Vytorin(R) Cholesterol Medication
6. New Data: Cholesterol Management Analysis of Upsher-Smiths Slo-Niacin(R) Tablets in Combination with Lipitor(R)
7. New Web Sites Educate About Triglycerides and HDL Cholesterol
8. Atherotech to Exhibit VAP(R) Cholesterol Test at American Heart Association Scientific Sessions 2009
9. U.S. Food and Drug Administration Approves CRESTOR(R) for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
10. New Data for Abbotts TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management
11. New Study Suggests Cholesterol-Lowering Statins Reduce Severe Asthma Attacks that Result in Hospitalizations and Emergency Room Visits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... 2017 A new Transparency Market Research report ... valued at US$0.53 bn in 2013 and is predicted to touch ... between 2014 and 2022. The title of the report is "Non-invasive ... Growth, Trends and Forecast 2014 - 2022." ... Non-invasive prenatal testing (NIPT), also referred to ...
(Date:1/23/2017)... SAN DIEGO , 23 janvier 2017  ResMed ... Winter Haven , Floride) ont annoncé aujourd,hui qu,ils se ... les litiges existants entre les parties. BMC et 3B ... de paiements de droits à ResMed, et ResMed effectuera ... à 3B pour clore le litige de Floride entre ...
(Date:1/23/2017)... Jan 23, 2017 NeuroVive Pharmaceutical AB ... signed a preclinical collaboration agreement with the Children,s Hospital of ... Falk , M.D., a US key opinion leader in the ... ... evaluate compounds from NeuroVive,s research program, NVP015, in certain experimental ...
Breaking Medicine Technology:
(Date:1/23/2017)... ... 23, 2017 , ... “Life Under Blankets”: an entrancing story about one ... Under Blankets” is the creation of published author, Kimberly Mitchell, who earned her bachelor’s ... went on to pursue a master’s degree in education in the field of curriculum ...
(Date:1/23/2017)... , ... January 23, 2017 , ... Valentine’s Day is a time when many people ... ones. For those who may be looking for the ideal present, Atlanta-based Perimeter Plastic ... get an additional $25 free. Or, spend $200 and get $50 free. , “A ...
(Date:1/22/2017)... FL (PRWEB) , ... January 22, 2017 , ... Zifam ... customers across the world, recently met with big-name retail buyers at the January ECRM ... evidence of efficacy and uses the utmost safety standards in all of its creations ...
(Date:1/22/2017)... TX (PRWEB) , ... January 22, 2017 , ... ... provide slow results. Often the results of a simple test will take days to ... Any Lab Test Now offers customers direct access to their lab tests, bypassing the ...
(Date:1/21/2017)... Raton, FL (PRWEB) , ... January 21, 2017 , ... ... Germany, announced it is bringing its product to the United States as part of ... over the last 25 years, Alcovit aims to reduce the productions of nasty toxins ...
Breaking Medicine News(10 mins):